Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
uniQure N.V. | Director | Ordinary Shares | 20.2K | $104K | $5.14 | Jun 13, 2024 | Direct |
Rallybio Corp | Director | Option (Right to Buy) | 16.5K | $29.2K | $1.77 | May 15, 2024 | Direct |
uniQure N.V. | Director | Stock Option (Right to Buy) | 17.1K | Jun 13, 2023 | Direct | ||
Dianthus Therapeutics, Inc. /DE/ | Director | Stock Option (Right to Buy) | 11K | May 23, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
QURE | uniQure N.V. | Jun 13, 2024 | 1 | -$11.4K | 4 | Jun 17, 2024 | Director |
DNTH | Dianthus Therapeutics, Inc. /DE/ | May 23, 2024 | 1 | $0 | 4 | May 28, 2024 | Director |
RLYB | Rallybio Corp | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
MGTA | Dianthus Therapeutics, Inc. /DE/ | Sep 11, 2023 | 1 | $0 | 4 | Sep 13, 2023 | Director |
MGTA | Dianthus Therapeutics, Inc. /DE/ | Sep 11, 2023 | 0 | $0 | 3 | Sep 13, 2023 | Director |
QURE | uniQure N.V. | Jun 13, 2023 | 3 | -$43.2K | 4 | Jun 20, 2023 | Director |
RLYB | Rallybio Corp | May 17, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
QURE | uniQure N.V. | Feb 27, 2023 | 1 | -$7.67K | 4 | Mar 1, 2023 | Director |
QURE | uniQure N.V. | Jan 18, 2023 | 3 | -$103K | 4 | Jan 20, 2023 | Director |
QURE | uniQure N.V. | Dec 13, 2022 | 6 | -$143K | 4 | Dec 15, 2022 | Director |
QURE | uniQure N.V. | Nov 29, 2022 | 3 | -$157K | 4 | Dec 1, 2022 | Director |
QURE | uniQure N.V. | Jun 15, 2022 | 2 | $0 | 4 | Jun 17, 2022 | Director |
RLYB | Rallybio Corp | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
QURE | uniQure N.V. | Feb 28, 2022 | 1 | -$10.1K | 4 | Mar 2, 2022 | Director |
QURE | uniQure N.V. | Feb 24, 2022 | 2 | $0 | 4 | Feb 28, 2022 | Director |
RLYB | Rallybio Corp | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |
RLYB | Rallybio Corp | Jul 29, 2021 | 0 | $0 | 3 | Jul 29, 2021 | Director |